Cargando…
Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model
Limb Girdle Muscular Dystrophy 2I (LGMDR9) is one of the most common LGMD characterized by defects in glycosylation of α-dystroglycan (matriglycan) resulting from mutations of Fukutin-related protein (FKRP). There is no effective therapy currently available. We recently demonstrated that ribitol sup...
Autores principales: | Wu, Bo, Drains, Morgan, Shah, Sapana N., Lu, Pei Juan, Leroy, Victoria, Killilee, Jessalyn, Rawls, Raegan, Tucker, Jason D., Blaeser, Anthony, Lu, Qi Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714851/ https://www.ncbi.nlm.nih.gov/pubmed/36454905 http://dx.doi.org/10.1371/journal.pone.0278482 |
Ejemplares similares
-
Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth
por: Lu, Pei J., et al.
Publicado: (2020) -
The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition
por: Praissman, Jeremy L, et al.
Publicado: (2016) -
Limb–Girdle Muscular Dystrophies Classification and Therapies
por: Bouchard, Camille, et al.
Publicado: (2023) -
ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice
por: Cataldi, Marcela P., et al.
Publicado: (2019) -
Limb-girdle Muscular Dystrophies in India: A Review
por: Khadilkar, Satish V., et al.
Publicado: (2017)